Binary events in healthcare can be key determinants of stock price performance. These can be especially relevant to investors seeking opportunity that is …
Shares of TrovaGene Inc (NASDAQ:TROV) climbed over 30% on Monday, after the drug maker announced that the first enrolled patient in the ongoing P1b/2 …
TrovaGene Inc (NASDAQ:TROV) just made the news official today: As revealed by SmarterAnalyst on Friday (when shares were already roaring up 30%), the U.S.
Healthcare analysts are weighing in on molecular diagnostics firm TrovaGene Inc (NASDAQ:TROV), pharmaceutical company Keryx Biopharmaceuticals (NASDAQ:KERX), and mological drug maker OHR Pharmaceutical Inc (NASDAQ:OHRP), as the …
Seadrill Ltd (NYSE:SDRL) is down over 7% due to falling oil prices resulting from a series of upcoming events. First, U.
Stone Energy Corporation Stone Energy Corporation (NYSE:SGY) shares lost almost one-third of their value today after the oil and gas company said it’s considering strategic …
Healthcare analysts came out today with research notes on a handful of biotechnology and medical stocks. Among the equities in focus are cancer …
TrovaGene Inc (NASDAQ:TROV), a developer of cell-free molecular diagnostics, announced today that it has entered into an Agreement with Fortified Provider Network (Fortified), a …
It’s a tale of two biotech firms this afternoon, as shares of TrovaGene Inc (NASDAQ:TROV) are up $0.73, or 20%, at $4.
TrovaGene Inc (NASDAQ:TROV), a developer of cell-free molecular diagnostics, announced that it has entered into an agreement with FedMed, Inc. (FedMed) establishing health benefit …
